AlphaMark Advisors »

SPDR S&P Pharmaceuticals shares owned by AlphaMark Advisors

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by AlphaMark Advisors from 13F filings

Historical chart of AlphaMark Advisors investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by AlphaMark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by AlphaMark Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $234k 5.9k 39.82

More positions owned by AlphaMark Advisors

AlphaMark Actively Man Etf (SMCP)
iShares S&P 500 Etf (IVV)
Procter & Gamble Company (PG)
Technology SPDR Etf (XLK)
Health Care SPDR Etf (XLV)
SPDR Trust Unit SR Etf (SPY)
Sch Fnd Em Lg Etf schb fdt emk lg (FNDE)
Db-x Msci Eafe Currency-hedged (DBEF)
Financial Select Sector SPDR (XLF)
Janus Detroit Str Tr (JAAA)
First Tr Exchng Traded Fd Vi tcw opportunis (FIXD)
Industrial SPDR (XLI)
Energy SPDR Etf (XLE)
Comms Svcs Sel SPDR Etf (XLC)
Consumer Staples Select Sect. SPDR (XLP)

View all positions for AlphaMark Advisors

Top funds holding SPDR S&P Pharmaceuticals

Clal Insurance Enterprises Holdings
Bank of America Corporation
Equitable Holdings
Kingsview Wealth Management
Morgan Stanley
LPL Financial
Wells Fargo & Company
Susquehanna International
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Jane Street
Bnp Paribas Arbitrage, Snc
Rockport Wealth
Wharton Business Group
UBS Group

View all funds holding SPDR S&P Pharmaceuticals